Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

por Rama, Tiago Azenha, Morgado, José Mário, Henriques, Ana, Escribano, Luis, Alvarez‐Twose, Iván, Sanchez‐Muñoz, Laura, Moreira, André, Romão, José, Órfão, Alberto, Matito, Almudena
Publicado 2022

Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature

por Alvarez-Twose, Iván, Matito, Almudena, Morgado, José Mário, Sánchez-Muñoz, Laura, Jara-Acevedo, María, García-Montero, Andrés, Mayado, Andrea, Caldas, Carolina, Teodósio, Cristina, Muñoz-González, Javier Ignacio, Mollejo, Manuela, Escribano, Luis, Orfao, Alberto
Publicado 2016

Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome

por Matito, Almudena, Morgado, José Mario, Álvarez-Twose, Iván, Laura Sánchez-Muñoz, Pedreira, Carlos Eduardo, Jara-Acevedo, María, Teodosio, Cristina, Sánchez-López, Paula, Fernández-Núñez, Elisa, Moreno-Borque, Ricardo, García-Montero, Andrés, Orfao, Alberto, Escribano, Luis
Publicado 2013